[go: up one dir, main page]

ES8604991A1 - Un metodo para preparar peptidos farmaceuticamente activos - Google Patents

Un metodo para preparar peptidos farmaceuticamente activos

Info

Publication number
ES8604991A1
ES8604991A1 ES545189A ES545189A ES8604991A1 ES 8604991 A1 ES8604991 A1 ES 8604991A1 ES 545189 A ES545189 A ES 545189A ES 545189 A ES545189 A ES 545189A ES 8604991 A1 ES8604991 A1 ES 8604991A1
Authority
ES
Spain
Prior art keywords
formula
preparation
peptido
atoms
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES545189A
Other languages
English (en)
Other versions
ES545189A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES545189A0 publication Critical patent/ES545189A0/es
Publication of ES8604991A1 publication Critical patent/ES8604991A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

METODO DE PREPARACION DE PEPTIDOS FARMACEUTICAMENTE ACTIVOS DE FORMULA (I) DONDE R1 ES HIDROGENO, ALQUILO DE C 1 A 2 ATOMOS DE C, O UN GRUPO AMIDINO; R2 ES ALQUILO DE 1 O 2 ATOMOS DE C; R3 ES HIDROGENO O CARBAMILO; X2 PUEDE SER UNO DE LOS RADICALES SIGUIENTES: 2-AMINO-4-GUANIDINOBUTIRILO (M ES 2), ARGINILO (M ES 3) Y HOMOARGINILO (M ES 4). HACIENDO REACCIONAR UN ACIDO PEPTIDO-CARBOXILICO DE FORMULA (II) O UN DERIVADO DEL MISMO CON UNA AMINA DE FORMULA (III), AMBOS REACTIVOS PROTEGIDOS Y/O ACTIVADOS EN LOS CASOS QUE SEA NECESARIO. EN LA ULTIMA ETAPA DE LA SINTESIS TIENE LUGAR LA AMIDACION DEL ACIDO PEPTIDO-CARBOXILICO C-TERMINAL CORRESPONDIENTE. DE UTILIZACION COMO ANALGESICO, ANTITUSIGENO, Y ANTIDIARREICO EN MEDICINA Y VETERINARIA.
ES545189A 1983-05-26 1985-07-15 Un metodo para preparar peptidos farmaceuticamente activos Expired ES8604991A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838314646A GB8314646D0 (en) 1983-05-26 1983-05-26 Pharmaceutical amides

Publications (2)

Publication Number Publication Date
ES545189A0 ES545189A0 (es) 1986-03-01
ES8604991A1 true ES8604991A1 (es) 1986-03-01

Family

ID=10543432

Family Applications (2)

Application Number Title Priority Date Filing Date
ES532813A Expired ES8606395A1 (es) 1983-05-26 1984-05-25 Un metodo de preparar peptidos farmaceuticamente activos
ES545189A Expired ES8604991A1 (es) 1983-05-26 1985-07-15 Un metodo para preparar peptidos farmaceuticamente activos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES532813A Expired ES8606395A1 (es) 1983-05-26 1984-05-25 Un metodo de preparar peptidos farmaceuticamente activos

Country Status (17)

Country Link
US (1) US4540682A (es)
EP (1) EP0127154B1 (es)
JP (1) JPS59231053A (es)
KR (1) KR850000467A (es)
AT (1) ATE57188T1 (es)
AU (1) AU575324B2 (es)
CA (1) CA1251898A (es)
DE (1) DE3483338D1 (es)
DK (1) DK258884A (es)
ES (2) ES8606395A1 (es)
FI (1) FI82254C (es)
GB (1) GB8314646D0 (es)
GR (1) GR81890B (es)
HU (1) HU193569B (es)
IL (1) IL71932A (es)
NZ (1) NZ208283A (es)
ZA (1) ZA844004B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8622090D0 (en) * 1986-09-12 1986-10-22 Wellcome Found Pharmacologically active compounds
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
WO1994025482A1 (en) * 1993-04-23 1994-11-10 Evans Herbert J Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6613508B1 (en) 1996-01-23 2003-09-02 Qiagen Genomics, Inc. Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
US6312893B1 (en) 1996-01-23 2001-11-06 Qiagen Genomics, Inc. Methods and compositions for determining the sequence of nucleic acid molecules
US6027890A (en) * 1996-01-23 2000-02-22 Rapigene, Inc. Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
WO1998007744A1 (fr) * 1996-08-23 1998-02-26 Sederma S.A. Peptides synthetiques et leur utilisation dans les compositions cosmetiques ou dermopharmaceutiques
DK2051991T3 (da) * 2006-08-17 2012-01-30 Eribis Pharmaceuticals Ab Cardiobeskyttende forbindelser

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178371A (en) * 1977-12-15 1979-12-11 Reckitt & Colman Products Limited Tetrapeptide derivatives
US4288432A (en) * 1979-06-12 1981-09-08 Richter Gedeon Vegyeszeti Gyar Rt. Novel enkephalin analogs and process for the preparation thereof
US4265808A (en) * 1979-12-17 1981-05-05 Eli Lilly And Company Pharmacologically active peptides
US4322339A (en) * 1980-10-20 1982-03-30 Eli Lilly And Company Pharmacologically active peptides

Also Published As

Publication number Publication date
ES545189A0 (es) 1986-03-01
FI82254B (fi) 1990-10-31
ES8606395A1 (es) 1986-04-01
DK258884D0 (da) 1984-05-25
IL71932A0 (en) 1984-09-30
GB8314646D0 (en) 1983-06-29
FI82254C (fi) 1991-02-11
AU575324B2 (en) 1988-07-28
EP0127154B1 (en) 1990-10-03
FI842104A0 (fi) 1984-05-25
HUT34764A (en) 1985-04-28
IL71932A (en) 1987-10-20
GR81890B (es) 1984-12-12
DE3483338D1 (de) 1990-11-08
CA1251898A (en) 1989-03-28
ES532813A0 (es) 1986-04-01
DK258884A (da) 1984-11-27
HU193569B (en) 1987-10-28
ATE57188T1 (de) 1990-10-15
ZA844004B (en) 1986-01-29
NZ208283A (en) 1988-07-28
FI842104L (fi) 1984-11-27
EP0127154A2 (en) 1984-12-05
AU2870184A (en) 1984-11-29
EP0127154A3 (en) 1987-05-06
KR850000467A (ko) 1985-02-27
JPS59231053A (ja) 1984-12-25
US4540682A (en) 1985-09-10

Similar Documents

Publication Publication Date Title
ES8604991A1 (es) Un metodo para preparar peptidos farmaceuticamente activos
UY24154A1 (es) Preparacion del acido clavulanico con ayuda de ciertas poliaminas
ES8607914A1 (es) Un procedimiento de preparar un derivado de trans-1,2-diaminociclohexil-amida.
ES2054826T3 (es) Peptidos con actividad inhibidora de colagenasa.
ES8401941A1 (es) Procedimiento para la preparacion de derivados de acido espiro (4.(3+n))-2-aza-3carboxilico.
FI810389L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
AR247732A1 (es) Procedimiento para obtener amidas de acido piridin-2, 4- y -2, 5-dicarboxilico
AR245933A1 (es) Procedimiento para preparar compuestos de 4-(3-hidroxifenil)metil-3-alquil-n-alquilpiperidina y sus sales.
ES8105696A1 (es) Procedimiento para la preparacion de polieterpoliaminas
ES8800667A1 (es) Procedimiento para preparar acidos quinolina-3-carboxilicos con propiedades antibacteriales
DK0629634T3 (da) Fremgangsmåde til fremstilling af taurocholansyrer
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
ES8307718A1 (es) "procedimiento de preparar amidoaminoacidos y similares".
ES8704153A1 (es) Un procedimiento para preparar derivados de pirimidina
GB947135A (en) Substituted amides
ES2033242T3 (es) Compuestos organicos y su uso farmaceutico.
ES2032482T3 (es) Derivados del bencilidenamino-, bencilamino- y benzoilamino-imidazol y su empleo como medicamentos. (reserva del art. 167.2 cpe).
ES2136626T3 (es) Peptidos con modificaciones en el extremo de n con efecto antagonista de bradiquinina.
ES8306106A1 (es) Procedimiento de preparacion de una n-acil-aspartil-taurina.
ATE26258T1 (de) Herstellung von phenylalaninen durch hydrierung von phenylserinen.
AR246511A1 (es) Acido 2-azabiciclo (2.2.1)hept-5-eno-2-acetico y derivados del mismo, procedimiento para su preparacion y procedimiento para preparar n-fosfonometilglicina con los mismos.
HUT48568A (en) Process for production of derivatives of amin-pirrelin acid and medical preparatives containing these substances
DK614989A (da) Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
DK0619817T3 (da) Hidtil ukendte farmaceutisk aktive flaviliumforbindelser
EP0119540A3 (en) Substituted alkylamine derivatives of 6,11-dihydro-11-oxodibenz (b,e)-oxepins, a process for the preparation and intermediates thereof and their use as medicaments